NeuroPace gains FDA approval for epilepsy device

11/15/2013 | Kansas City Star (Mo.), The

The FDA has granted NeuroPace approval for its RNS System, an implantable device designed to minimize seizures in patients with epilepsy who have failed to respond to medications. The neurostimulator works by sending electrical pulses to areas in the brain believed to be triggering the seizures.

View Full Article in:

Kansas City Star (Mo.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC